These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 12062115)

  • 1. Temperature modulation of DHPLC analysis for detection of coexisting constitutional and mosaic sequence variants in TSC2.
    Antonarakis ES; Sampson JR; Cheadle JP
    J Biochem Biophys Methods; 2002 Apr; 51(2):161-4. PubMed ID: 12062115
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterizing mutations in samples with low-level mosaicism by collection and analysis of DHPLC fractionated heteroduplexes.
    Emmerson P; Maynard J; Jones S; Butler R; Sampson JR; Cheadle JP
    Hum Mutat; 2003 Feb; 21(2):112-5. PubMed ID: 12552557
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Superiority of denaturing high performance liquid chromatography over single-stranded conformation and conformation-sensitive gel electrophoresis for mutation detection in TSC2.
    Choy YS; Dabora SL; Hall F; Ramesh V; Niida Y; Franz D; Kasprzyk-Obara J; Reeve MP; Kwiatkowski DJ
    Ann Hum Genet; 1999 Sep; 63(Pt 5):383-91. PubMed ID: 10735580
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Denaturing high-performance liquid chromatography (DHPLC) is a highly sensitive, semi-automated method for identifying mutations in the TSC1 gene.
    Roberts PS; Jozwiak S; Kwiatkowski DJ; Dabora SL
    J Biochem Biophys Methods; 2001 Jan; 47(1-2):33-7. PubMed ID: 11179759
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Optimal temperature selection for mutation detection by denaturing HPLC and comparison to single-stranded conformation polymorphism and heteroduplex analysis.
    Jones AC; Austin J; Hansen N; Hoogendoorn B; Oefner PJ; Cheadle JP; O'Donovan MC
    Clin Chem; 1999 Aug; 45(8 Pt 1):1133-40. PubMed ID: 10430776
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ultra deep sequencing detects a low rate of mosaic mutations in tuberous sclerosis complex.
    Qin W; Kozlowski P; Taillon BE; Bouffard P; Holmes AJ; Janne P; Camposano S; Thiele E; Franz D; Kwiatkowski DJ
    Hum Genet; 2010 Mar; 127(5):573-82. PubMed ID: 20165957
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Denaturing high-performance liquid chromatography (DHPLC)-based prenatal diagnosis for tuberous sclerosis.
    Bénit P; Bonnefont JP; Kara Mostefa A; Francannet C; Munnich A; Ray PF
    Prenat Diagn; 2001 Apr; 21(4):279-83. PubMed ID: 11288117
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High rate of mosaicism in tuberous sclerosis complex.
    Verhoef S; Bakker L; Tempelaars AM; Hesseling-Janssen AL; Mazurczak T; Jozwiak S; Fois A; Bartalini G; Zonnenberg BA; van Essen AJ; Lindhout D; Halley DJ; van den Ouweland AM
    Am J Hum Genet; 1999 Jun; 64(6):1632-7. PubMed ID: 10330349
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The GAP-related domain of tuberin, the product of the TSC2 gene, is a target for missense mutations in tuberous sclerosis.
    Maheshwar MM; Cheadle JP; Jones AC; Myring J; Fryer AE; Harris PC; Sampson JR
    Hum Mol Genet; 1997 Oct; 6(11):1991-6. PubMed ID: 9302281
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular genetic and phenotypic analysis reveals differences between TSC1 and TSC2 associated familial and sporadic tuberous sclerosis.
    Jones AC; Daniells CE; Snell RG; Tachataki M; Idziaszczyk SA; Krawczak M; Sampson JR; Cheadle JP
    Hum Mol Genet; 1997 Nov; 6(12):2155-61. PubMed ID: 9328481
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular genetic advances in tuberous sclerosis.
    Cheadle JP; Reeve MP; Sampson JR; Kwiatkowski DJ
    Hum Genet; 2000 Aug; 107(2):97-114. PubMed ID: 11030407
    [TBL] [Abstract][Full Text] [Related]  

  • 12. TSC1 and TSC2: genes that are mutated in the human genetic disorder tuberous sclerosis.
    Sampson JR
    Biochem Soc Trans; 2003 Jun; 31(Pt 3):592-6. PubMed ID: 12773162
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Application of the protein truncation test (PTT) for the detection of tuberculosis sclerosis complex type 1 and 2 (TSC1 and TSC2) mutations.
    Mayer K
    Methods Mol Biol; 2003; 217():329-44. PubMed ID: 12491945
    [No Abstract]   [Full Text] [Related]  

  • 14. Novel TSC1 and TSC2 mutations in Japanese patients with tuberous sclerosis complex.
    Yamamoto T; Pipo JR; Feng JH; Takeda H; Nanba E; Ninomiya H; Ohno K
    Brain Dev; 2002 Jun; 24(4):227-30. PubMed ID: 12015165
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Low level mosaicism detectable by DHPLC but not by direct sequencing.
    Jones AC; Sampson JR; Cheadle JP
    Hum Mutat; 2001 Mar; 17(3):233-4. PubMed ID: 11241845
    [No Abstract]   [Full Text] [Related]  

  • 16. Molecular analysis of the TSC1 and TSC2 tumour suppressor genes in sporadic glial and glioneuronal tumours.
    Parry L; Maynard JH; Patel A; Hodges AK; von Deimling A; Sampson JR; Cheadle JP
    Hum Genet; 2000 Oct; 107(4):350-6. PubMed ID: 11129334
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pathogenesis of tuberous sclerosis subependymal giant cell astrocytomas: biallelic inactivation of TSC1 or TSC2 leads to mTOR activation.
    Chan JA; Zhang H; Roberts PS; Jozwiak S; Wieslawa G; Lewin-Kowalik J; Kotulska K; Kwiatkowski DJ
    J Neuropathol Exp Neurol; 2004 Dec; 63(12):1236-42. PubMed ID: 15624760
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of the tuberous sclerosis gene TSC1 on chromosome 9q34.
    van Slegtenhorst M; de Hoogt R; Hermans C; Nellist M; Janssen B; Verhoef S; Lindhout D; van den Ouweland A; Halley D; Young J; Burley M; Jeremiah S; Woodward K; Nahmias J; Fox M; Ekong R; Osborne J; Wolfe J; Povey S; Snell RG; Cheadle JP; Jones AC; Tachataki M; Ravine D; Sampson JR; Reeve MP; Richardson P; Wilmer F; Munro C; Hawkins TL; Sepp T; Ali JB; Ward S; Green AJ; Yates JR; Kwiatkowska J; Henske EP; Short MP; Haines JH; Jozwiak S; Kwiatkowski DJ
    Science; 1997 Aug; 277(5327):805-8. PubMed ID: 9242607
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Drosophila Tsc1 functions with Tsc2 to antagonize insulin signaling in regulating cell growth, cell proliferation, and organ size.
    Potter CJ; Huang H; Xu T
    Cell; 2001 May; 105(3):357-68. PubMed ID: 11348592
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Analysis of both TSC1 and TSC2 for germline mutations in 126 unrelated patients with tuberous sclerosis.
    Niida Y; Lawrence-Smith N; Banwell A; Hammer E; Lewis J; Beauchamp RL; Sims K; Ramesh V; Ozelius L
    Hum Mutat; 1999; 14(5):412-22. PubMed ID: 10533067
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.